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showing a significant seasonal pattern in Iran 
(p = 0.001), as had been reported in Lebanon. 
In Beirut, weather pattern analysis revealed 
clustering of onset of invasive mucormycosis 
at the end of a dry, warm period, which begins 
around May and ends in October,4 which was 
similar to the time of occurring symptoms in 
our patients (Figure 1).
The study highlights the importance of 
increased awareness for early diagnosis of zy-
gomycosis and aggressive management. Mu-
cormycosis incidence appears to be seasonal in 
Iran. This disease and its treatments are still as-
sociated with severe morbidity, disfigurement 
and disability.
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Dear Editor,
Zygomycosis, earlier considered as rare entity, 
is being reported with increasing frequency in 
recent years.1 Classically described predispos-
ing factors include poorly controlled diabetes, 
especially when associated with ketoacidosis, 
corticosteroid use, immunosuppression ther-
apy for solid organ transplant or bone marrow 
transplant, neutropenia or neutrophil dysfunc-
tion associated with leukemia/lymphoma.2,3 
In one study in Lebanon, it has been reported 
that mucormycosis incidence appears to be sea-
sonal in the Eastern Mediterranean and cluster-
ing of onset of invasive mucormycosis begins 
around May and ends in October.4 In order to 
understand the whole gamut of the disease in 
the Iranian scenario, we undertook a retrospec-
tive analysis of such cases diagnosed with his-
topathologic confirmation in our institute over 
the last seven years (2003-2009). In this study 
we reported 27 patients with zygomycosis from 
61 cases with suspected mucormycosis from a 
single center (Hzt Rasool-e-Akram Hospital, a 
tertiary care center), with special reference to its 
prevalence, sites of involvement, underlying dis-
eases, time of diagnosis and treatment strategy.
Higher prevalence rate (29.6%) was ob-
served in 2009. Rhino-orbito-cerebral type 
(100%) was the only presentation which can be 
categorized as nasal-paranasal sinuses (77.8%), 
orbital (11.1%) and nasal-paranasal sinuses-or-
bital (11.1%) involvement. Diabetes mellitus (in 
55.7% of cases) was the most common under-
lying condition followed by hematologic ma-
lignancy (22.2%). Twenty-six cases treated with 
combination of aggressive surgical debride-
ment of necrotic tissue and amphotericin-B ex-
cept for one case treated with amphotericin-B 
alone. Medical therapy included conventional 
amphotericin B (CAB) in most cases and in one 
patient liposomal amphotericin B was used. In 
this study, onset of symptoms occurred in the 
summer and autumn in 21 out of 27 patients, 
Figure 1: Seasonal distribution of zygomycosis 
cases.
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